drugset / Trial / NCT00989157
Effects of Gastric Bypass on Blood Levels of Duloxetine
Phase 3
Completed
20 enrolled
Neuropsychiatric Research Institute, Fargo, North Dakota
Eli Lilly and Company · collabUniversity of North Dakota · collab
NaSingle-groupOpen-labelBasic science
Summary
This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Timeline
- Start
- 2009-09
- Primary completion
- 2012-10
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 60 mg | — |
Indications
No indication recorded.